Hypermarcas (OTCMKTS:HYPMY) Sees Large Increase in Short Interest

Hypermarcas (OTCMKTS:HYPMY – Get Free Report) was the target of a large growth in short interest in the month of August. As of August 14th, there was short interest totaling 9,271 shares, a growth of 184.7% from the July 30th total of 3,256 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average trading volume of 23,806 shares, the days-to-cover ratio is currently 0.4 days.

Hypermarcas Trading Up 0.7%

Shares of Hypermarcas stock traded up $0.03 on Friday, reaching $4.12. 1,778 shares of the stock were exchanged, compared to its average volume of 9,595. Hypermarcas has a 1-year low of $3.71 and a 1-year high of $5.50. The business has a fifty day moving average price of $4.11 and a two-hundred day moving average price of $4.29. The firm has a market capitalization of $2.90 billion, a PE ratio of 8.24 and a beta of 0.70.

Get Hypermarcas alerts:

Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.14 EPS for the quarter, beating analysts’ consensus estimates of $0.13 by $0.01. Hypermarcas had a net margin of 19.77% and a return on equity of 14.63%. Research analysts expect that Hypermarcas will post 0.53 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group upgraded shares of Hypermarcas to a “strong-buy” rating in a research note on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Buy”.

Get Our Latest Report on HYPMY

Hypermarcas Company Profile

(Get Free Report)

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.

See Also

• Five stocks we like better than Hypermarcas
• From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
• These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
• Venture Into High-Volatility Corners of the Market With These 3 ETFs
• 3 Retail Stocks to Watch After a Big Consumer Earnings Week

Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.